Cargando…

Long-term exposure to PM(2.5) and cardiovascular disease incidence and mortality in an Eastern Mediterranean country: findings based on a 15-year cohort study

BACKGROUND: Evidence concerning the impact of long-term exposure to fine Particulate Matter ≤2.5 μm (PM(2.5)) on Cardio-Vascular Diseases (CVDs) for those people subject to ambient air pollution in developing countries remains relatively scant. This study assessed the relationship of 15-year PM(2.5)...

Descripción completa

Detalles Bibliográficos
Autores principales: Jalali, Soheila, Karbakhsh, Mojgan, Momeni, Mehdi, Taheri, Marzieh, Amini, Saeid, Mansourian, Marjan, Sarrafzadegan, Nizal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555193/
https://www.ncbi.nlm.nih.gov/pubmed/34711250
http://dx.doi.org/10.1186/s12940-021-00797-w
_version_ 1784591928268947456
author Jalali, Soheila
Karbakhsh, Mojgan
Momeni, Mehdi
Taheri, Marzieh
Amini, Saeid
Mansourian, Marjan
Sarrafzadegan, Nizal
author_facet Jalali, Soheila
Karbakhsh, Mojgan
Momeni, Mehdi
Taheri, Marzieh
Amini, Saeid
Mansourian, Marjan
Sarrafzadegan, Nizal
author_sort Jalali, Soheila
collection PubMed
description BACKGROUND: Evidence concerning the impact of long-term exposure to fine Particulate Matter ≤2.5 μm (PM(2.5)) on Cardio-Vascular Diseases (CVDs) for those people subject to ambient air pollution in developing countries remains relatively scant. This study assessed the relationship of 15-year PM(2.5) exposure with cardiovascular incidence and mortality rate in Isfahan province, Iran. METHODS: The cohort comprised 3081 participants over 35 years old who were free of CVDs. They were selected through multi-stage cluster sampling in Isfahan, Iran. PM(2.5) exposure was determined separately for each individual via satellite-based spatiotemporal estimates according to their residential addresses. In this context, CVD is defined as either fatal and non-fatal Acute Myocardial Infarctions (AMI) or stroke and sudden cardiac death. The incidence risk for CVD and the ensuing mortality was calculated based on the average PM(2.5) exposure within a study period of 15 years using the Cox proportional hazards frailty model upon adjusting individual risk factors. The mean annual rate of PM(2.5) and the follow-up data of each residential area were combined. RESULTS: Mean three-year PM(2·5) exposure for the cohort was measured at 45.28 μg/m(3), ranging from 20.01 to 69.80 μg/m(3). The median time period for conducting necessary follow-ups was 12.3 years for the whole population. Notably, 105 cardiovascular and 241 all-cause deaths occurred among 393,786 person-months (27 and 61 per 100,000 person-months, respectively). In well-adjusted models, 10 μg/m(3) increase in PM(2.5) corresponded to a 3% increase in the incidence rate of CVDs [0.95 CI = 1.016, 1.036] (in case of p = 0.000001 per 10 μg/m(3) increase in PM(2.5), the Hazard Ratio (HR) for AMI and Ischemic Heart Disease (IHD) was 1.031 [0.95 CI = 1.005, 1.057] and 1.028 [0.95 CI = 1.017, 1.039]), respectively. No consistent association was observed between PM(2.5) concentration and fatal CVD (fatal AMI, fatal stroke, SCD (Sudden Cardiac Death)) and all-cause mortality. CONCLUSIONS: Results from analyses suggest that the effect of PM(2.5) on cardiovascular disease occurrence was stronger in the case of older people, smokers, and those with high blood pressure and diabetes. The final results revealed that long-term exposure to ambient PM(2.5) with high concentrations positively correlated with IHD incidence and its major subtypes, except for mortality. The outcome accentuates the need for better air quality in many countries. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12940-021-00797-w.
format Online
Article
Text
id pubmed-8555193
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85551932021-10-29 Long-term exposure to PM(2.5) and cardiovascular disease incidence and mortality in an Eastern Mediterranean country: findings based on a 15-year cohort study Jalali, Soheila Karbakhsh, Mojgan Momeni, Mehdi Taheri, Marzieh Amini, Saeid Mansourian, Marjan Sarrafzadegan, Nizal Environ Health Research BACKGROUND: Evidence concerning the impact of long-term exposure to fine Particulate Matter ≤2.5 μm (PM(2.5)) on Cardio-Vascular Diseases (CVDs) for those people subject to ambient air pollution in developing countries remains relatively scant. This study assessed the relationship of 15-year PM(2.5) exposure with cardiovascular incidence and mortality rate in Isfahan province, Iran. METHODS: The cohort comprised 3081 participants over 35 years old who were free of CVDs. They were selected through multi-stage cluster sampling in Isfahan, Iran. PM(2.5) exposure was determined separately for each individual via satellite-based spatiotemporal estimates according to their residential addresses. In this context, CVD is defined as either fatal and non-fatal Acute Myocardial Infarctions (AMI) or stroke and sudden cardiac death. The incidence risk for CVD and the ensuing mortality was calculated based on the average PM(2.5) exposure within a study period of 15 years using the Cox proportional hazards frailty model upon adjusting individual risk factors. The mean annual rate of PM(2.5) and the follow-up data of each residential area were combined. RESULTS: Mean three-year PM(2·5) exposure for the cohort was measured at 45.28 μg/m(3), ranging from 20.01 to 69.80 μg/m(3). The median time period for conducting necessary follow-ups was 12.3 years for the whole population. Notably, 105 cardiovascular and 241 all-cause deaths occurred among 393,786 person-months (27 and 61 per 100,000 person-months, respectively). In well-adjusted models, 10 μg/m(3) increase in PM(2.5) corresponded to a 3% increase in the incidence rate of CVDs [0.95 CI = 1.016, 1.036] (in case of p = 0.000001 per 10 μg/m(3) increase in PM(2.5), the Hazard Ratio (HR) for AMI and Ischemic Heart Disease (IHD) was 1.031 [0.95 CI = 1.005, 1.057] and 1.028 [0.95 CI = 1.017, 1.039]), respectively. No consistent association was observed between PM(2.5) concentration and fatal CVD (fatal AMI, fatal stroke, SCD (Sudden Cardiac Death)) and all-cause mortality. CONCLUSIONS: Results from analyses suggest that the effect of PM(2.5) on cardiovascular disease occurrence was stronger in the case of older people, smokers, and those with high blood pressure and diabetes. The final results revealed that long-term exposure to ambient PM(2.5) with high concentrations positively correlated with IHD incidence and its major subtypes, except for mortality. The outcome accentuates the need for better air quality in many countries. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12940-021-00797-w. BioMed Central 2021-10-28 /pmc/articles/PMC8555193/ /pubmed/34711250 http://dx.doi.org/10.1186/s12940-021-00797-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Jalali, Soheila
Karbakhsh, Mojgan
Momeni, Mehdi
Taheri, Marzieh
Amini, Saeid
Mansourian, Marjan
Sarrafzadegan, Nizal
Long-term exposure to PM(2.5) and cardiovascular disease incidence and mortality in an Eastern Mediterranean country: findings based on a 15-year cohort study
title Long-term exposure to PM(2.5) and cardiovascular disease incidence and mortality in an Eastern Mediterranean country: findings based on a 15-year cohort study
title_full Long-term exposure to PM(2.5) and cardiovascular disease incidence and mortality in an Eastern Mediterranean country: findings based on a 15-year cohort study
title_fullStr Long-term exposure to PM(2.5) and cardiovascular disease incidence and mortality in an Eastern Mediterranean country: findings based on a 15-year cohort study
title_full_unstemmed Long-term exposure to PM(2.5) and cardiovascular disease incidence and mortality in an Eastern Mediterranean country: findings based on a 15-year cohort study
title_short Long-term exposure to PM(2.5) and cardiovascular disease incidence and mortality in an Eastern Mediterranean country: findings based on a 15-year cohort study
title_sort long-term exposure to pm(2.5) and cardiovascular disease incidence and mortality in an eastern mediterranean country: findings based on a 15-year cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555193/
https://www.ncbi.nlm.nih.gov/pubmed/34711250
http://dx.doi.org/10.1186/s12940-021-00797-w
work_keys_str_mv AT jalalisoheila longtermexposuretopm25andcardiovasculardiseaseincidenceandmortalityinaneasternmediterraneancountryfindingsbasedona15yearcohortstudy
AT karbakhshmojgan longtermexposuretopm25andcardiovasculardiseaseincidenceandmortalityinaneasternmediterraneancountryfindingsbasedona15yearcohortstudy
AT momenimehdi longtermexposuretopm25andcardiovasculardiseaseincidenceandmortalityinaneasternmediterraneancountryfindingsbasedona15yearcohortstudy
AT taherimarzieh longtermexposuretopm25andcardiovasculardiseaseincidenceandmortalityinaneasternmediterraneancountryfindingsbasedona15yearcohortstudy
AT aminisaeid longtermexposuretopm25andcardiovasculardiseaseincidenceandmortalityinaneasternmediterraneancountryfindingsbasedona15yearcohortstudy
AT mansourianmarjan longtermexposuretopm25andcardiovasculardiseaseincidenceandmortalityinaneasternmediterraneancountryfindingsbasedona15yearcohortstudy
AT sarrafzadegannizal longtermexposuretopm25andcardiovasculardiseaseincidenceandmortalityinaneasternmediterraneancountryfindingsbasedona15yearcohortstudy